Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CEO and Director

CEO,CSO and Director

Chief Financial Officer

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in phase 2 clinical development for the treatment of non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-27	Premium	bought	Premium	Premium	Premium	-
2023-11-24	Premium	bought	Premium	Premium	Premium	-
2023-09-19	Premium	bought	Premium	Premium	Premium	-
2023-09-18	Premium	bought	Premium	Premium	Premium	CEO and Director
2023-09-15	Premium	bought	Premium	Premium	Premium	CEO,CSO and Director
2023-09-15	Premium	bought	Premium	Premium	Premium	-
2021-02-18	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-02-18	Premium	bought	Premium	Premium	Premium	CEO and Director
2021-02-16	Premium	bought	Premium	Premium	Premium	-
2020-12-18	Premium	bought	Premium	Premium	Premium	-
2020-12-08	Premium	bought	Premium	Premium	Premium	CEO and Director
2020-12-02	Premium	bought	Premium	Premium	Premium	-
2020-12-01	Premium	bought	Premium	Premium	Premium	-
2020-11-25	Premium	bought	Premium	Premium	Premium	Chief Financial Officer

HEPA - Hepion Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for HEPA